• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性摄入饮用水中的砷会导致内脏利什曼病小鼠模型对抗锑药物产生耐药性。

Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis.

机构信息

Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, United Kingdom.

出版信息

Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19932-7. doi: 10.1073/pnas.1311535110. Epub 2013 Oct 28.

DOI:10.1073/pnas.1311535110
PMID:24167266
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3856816/
Abstract

The Indian subcontinent is the only region where arsenic contamination of drinking water coexists with widespread resistance to antimonial drugs that are used to treat the parasitic disease visceral leishmaniasis. We have previously proposed that selection for parasite resistance within visceral leishmaniasis patients who have been exposed to trivalent arsenic results in cross-resistance to the related metalloid antimony, present in the pentavalent state as a complex in drugs such as sodium stibogluconate (Pentostam) and meglumine antimonate (Glucantime). To test this hypothesis, Leishmania donovani was serially passaged in mice exposed to arsenic in drinking water at environmentally relevant levels (10 or 100 ppm). Arsenic accumulation in organs and other tissues was proportional to the level of exposure and similar to that previously reported in human liver biopsies. After five monthly passages in mice exposed to arsenic, isolated parasites were found to be completely refractory to 500 μg · mL(-1) Pentostam compared with the control passage group (38.5 μg · mL(-1)) cultured in vitro in mouse peritoneal macrophages. Reassessment of resistant parasites following further passage for 4 mo in mice without arsenic exposure showed that resistance was stable. Treatment of infected mice with Pentostam confirmed that resistance observed in vitro also occurred in vivo. We conclude that arsenic contamination may have played a significant role in the development of Leishmania antimonial resistance in Bihar because inadequate treatment with antimonial drugs is not exclusive to India, whereas widespread antimonial resistance is.

摘要

印度次大陆是唯一一个饮用水砷污染与广泛抗锑药物耐药并存的地区,而这些抗锑药物被用于治疗寄生虫病内脏利什曼病。我们之前曾提出,在接触三价砷的内脏利什曼病患者中,寄生虫耐药性的选择导致对相关类金属锑的交叉耐药,而锑在五价状态下以复杂形式存在于药物中,如葡萄糖酸锑钠(Pentostam)和葡甲胺锑(Glucantime)。为了验证这一假设,我们在环境相关水平(10 或 100 ppm)的饮用水中暴露于砷的小鼠中对利什曼原虫(Leishmania donovani)进行了连续传代。器官和其他组织中的砷积累与暴露水平成正比,与之前在人类肝活检中报道的相似。在暴露于砷的小鼠中进行了五次每月传代后,与在体外培养于小鼠腹腔巨噬细胞中的对照传代组(38.5 μg·mL(-1))相比,分离的寄生虫对 500 μg·mL(-1) Pentostam 完全耐药。在没有砷暴露的小鼠中进一步传代 4 个月后重新评估耐药寄生虫,发现耐药性稳定。用 Pentostam 治疗感染小鼠证实了体外观察到的耐药性也发生在体内。我们得出结论,砷污染可能在比哈尔邦利什曼原虫抗锑耐药性的发展中发挥了重要作用,因为抗锑药物的治疗不足不仅在印度存在,而且广泛存在抗锑耐药性。

相似文献

1
Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis.慢性摄入饮用水中的砷会导致内脏利什曼病小鼠模型对抗锑药物产生耐药性。
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19932-7. doi: 10.1073/pnas.1311535110. Epub 2013 Oct 28.
2
Chronic arsenic exposure and microbial drug resistance.慢性砷暴露与微生物耐药性。
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19666-7. doi: 10.1073/pnas.1319659110. Epub 2013 Nov 13.
3
Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar?砷、锑与利什曼原虫:印度饮用水砷污染是否导致了治疗抵抗性黑热病?
Lancet. 2015 Feb 26;385 Suppl 1:S80. doi: 10.1016/S0140-6736(15)60395-6.
4
Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study.印度比哈尔邦内脏利什曼病患者接触砷和锑剂治疗结果:一项回顾性队列研究。
PLoS Negl Trop Dis. 2015 Mar 2;9(3):e0003518. doi: 10.1371/journal.pntd.0003518. eCollection 2015 Mar.
5
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?内脏利什曼病与砷:一种导致印度次大陆锑剂治疗失败的古老毒药?
PLoS Negl Trop Dis. 2011 Sep;5(9):e1227. doi: 10.1371/journal.pntd.0001227. Epub 2011 Sep 27.
6
Comparison of Resistance of Wild İsolates, Which are Resistant to Pentavalent Antimonial Compounds, Against Drugs Used in the Treatment of Leishmaniasis.对五价锑化合物耐药的野生分离株对用于治疗利什曼病的药物的耐药性比较。
Turkiye Parazitol Derg. 2020 Mar 20;44(1):12-16. doi: 10.4274/tpd.galenos.2019.6661.
7
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.利什曼原虫中物种特异性的锑敏感性由水通道蛋白1(AQP1)的转录后调控驱动。
PLoS Negl Trop Dis. 2015 Feb 25;9(2):e0003500. doi: 10.1371/journal.pntd.0003500. eCollection 2015 Feb.
8
[Treatment of visceral leishmaniasis in children].[儿童内脏利什曼病的治疗]
Med Trop (Mars). 2007 Feb;67(1):73-8.
9
Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.甘草酸与抗利什曼原虫药物葡萄糖酸锑钠(SAG)联合用药可治愈 SAG 耐药性内脏利什曼病。
Int J Antimicrob Agents. 2015 Mar;45(3):268-77. doi: 10.1016/j.ijantimicag.2014.10.023. Epub 2014 Dec 8.
10
Glucantime resistant Leishmania promastigotes are sensitive to pentostam.对葡糖胺锑钠耐药的利什曼原虫前鞭毛体对喷他脒敏感。
Rev Soc Bras Med Trop. 1992 Oct-Dec;25(4):247-50. doi: 10.1590/s0037-86821992000400006.

引用本文的文献

1
Chronic arsenic exposure and hsa-miR-186 overexpression causes transcriptome-wide differential alternative splicing contributing to skin carcinogenesis in human HaCaT cell line.慢性砷暴露和hsa-miR-186过表达导致全转录组范围的差异可变剪接,促进人HaCaT细胞系中的皮肤癌发生。
Arch Toxicol. 2025 Jun 13. doi: 10.1007/s00204-025-04104-1.
2
Dysregulation of mRNA expression by hsa-miR-186 overexpression in arsenic-induced skin carcinogenesis.在砷诱导的皮肤癌发生过程中,hsa-miR-186过表达导致mRNA表达失调。
Toxicol Appl Pharmacol. 2025 Feb;495:117209. doi: 10.1016/j.taap.2024.117209. Epub 2024 Dec 22.
3
Drugs for Vector-Borne Protozoal Diseases in a One Health Scenario. A European Perspective.《One Health 背景下的虫媒原生动物病药物治疗:欧洲视角》
ACS Infect Dis. 2024 Nov 8;10(11):3715-3720. doi: 10.1021/acsinfecdis.4c00339. Epub 2024 Oct 29.
4
Environmental behavior, human health effect, and pollution control of heavy metal(loid)s toward full life cycle processes.重金属(类金属)在整个生命周期过程中的环境行为、对人类健康的影响及污染控制
Eco Environ Health. 2022 Nov 29;1(4):229-243. doi: 10.1016/j.eehl.2022.11.003. eCollection 2022 Dec.
5
Arsenic exposure to mouse visceral leishmaniasis model through their drinking water linked to the disease exacerbation via modulation in host protective immunity: a preclinical study.通过饮用水向感染内脏利什曼病的小鼠模型暴露砷与通过调节宿主保护性免疫导致疾病恶化有关:一项临床前研究。
Sci Rep. 2023 Dec 5;13(1):21461. doi: 10.1038/s41598-023-48642-z.
6
Antimony resistance and gene expression in : spotlight on molecular and proteomic aspects.抗锑性与 : 分子和蛋白质组学方面的基因表达研究焦点。
Parasitology. 2024 Jan;151(1):1-14. doi: 10.1017/S0031182023001129. Epub 2023 Nov 28.
7
The adaptive roles of aneuploidy and polyclonality in Leishmania in response to environmental stress.非整倍体和多克隆性在利什曼原虫应对环境压力中的适应作用。
EMBO Rep. 2023 Sep 6;24(9):e57413. doi: 10.15252/embr.202357413. Epub 2023 Jul 20.
8
AS3MT facilitates NLRP3 inflammasome activation by mA modification during arsenic-induced hepatic insulin resistance.砷诱导的肝胰岛素抵抗中,AS3MT 通过 mA 修饰促进 NLRP3 炎性小体激活。
Cell Biol Toxicol. 2023 Oct;39(5):2165-2181. doi: 10.1007/s10565-022-09703-7. Epub 2022 Feb 28.
9
Laboratory Selection of Trypanosomatid Pathogens for Drug Resistance.用于耐药性研究的锥虫病原体的实验室筛选
Pharmaceuticals (Basel). 2022 Jan 24;15(2):135. doi: 10.3390/ph15020135.
10
Identification of 3-Methoxycarpachromene and Masticadienonic Acid as New Target Inhibitors against Trypanothione Reductase from Using Molecular Docking and ADMET Prediction.利用分子对接和 ADMET 预测鉴定 3-甲氧基卡波烯和乳香烯酸作为新型抗锥虫硫醇还原酶的靶标抑制剂。
Molecules. 2021 Jun 1;26(11):3335. doi: 10.3390/molecules26113335.

本文引用的文献

1
The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis.抗锥虫药物非昔硝唑显示出治疗内脏利什曼病的潜力。
Sci Transl Med. 2012 Feb 1;4(119):119re1. doi: 10.1126/scitranslmed.3003326.
2
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?内脏利什曼病与砷:一种导致印度次大陆锑剂治疗失败的古老毒药?
PLoS Negl Trop Dis. 2011 Sep;5(9):e1227. doi: 10.1371/journal.pntd.0001227. Epub 2011 Sep 27.
3
Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden.杜氏利什曼原虫中的锑耐药性与体内寄生虫负担增加有关。
PLoS One. 2011;6(8):e23120. doi: 10.1371/journal.pone.0023120. Epub 2011 Aug 1.
4
Leishmania antimony resistance: what we know what we can learn from the field.利什曼原虫锑剂耐药性:我们所知与可从该领域借鉴之处。
Parasitol Res. 2011 Nov;109(5):1225-32. doi: 10.1007/s00436-011-2555-5. Epub 2011 Jul 29.
5
Visceral leishmaniasis: elimination with existing interventions.内脏利什曼病:利用现有干预措施消除。
Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0.
6
Management of visceral leishmaniasis in rural primary health care services in Bihar, India.印度比哈尔邦农村初级卫生保健服务中内脏利什曼病的管理。
Trop Med Int Health. 2010 Jul;15 Suppl 2(Suppl 2):55-62. doi: 10.1111/j.1365-3156.2010.02562.x.
7
In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.抗利什曼原虫药物对利什曼原虫的体外活性依赖于宿主细胞。
J Antimicrob Chemother. 2010 Mar;65(3):508-11. doi: 10.1093/jac/dkp500. Epub 2010 Jan 20.
8
Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.砷诱导的致癌作用——氧化应激作为一种可能的作用模式,以及未来基于生物学的风险评估的更多研究需求。
Chem Res Toxicol. 2010 Feb 15;23(2):327-35. doi: 10.1021/tx900343d.
9
Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal.尼泊尔采用五价锑剂治疗黑热病患者中治疗失败的临床危险因素。
Trans R Soc Trop Med Hyg. 2010 Mar;104(3):225-9. doi: 10.1016/j.trstmh.2009.08.002. Epub 2009 Sep 1.
10
Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice.生命阶段和暴露持续时间对C3H小鼠砷诱导的增殖性病变和肿瘤形成的影响。
Toxicology. 2009 Aug 3;262(2):106-13. doi: 10.1016/j.tox.2009.05.003. Epub 2009 May 18.